Aratana Therapeutics Inc (PETX)

9.36
0.45 5.05
NASDAQ : Health Care
Prev Close 8.91
Open 9.00
Day Low/High 8.90 / 9.39
52 Wk Low/High 2.56 / 19.99
Volume 842.98K
Avg Volume 725.60K
Exchange NASDAQ
Shares Outstanding 35.42M
Market Cap 315.55M
EPS -2.50
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Shark Bites: Not Much Reason to Buy in This Environment

I'm even staying away from the appealing stocks.

For Traders, Planning Is More Important Than the Plan

For Traders, Planning Is More Important Than the Plan

Because every stock has a unique personality that requires its own strategy.

Shark Bites: Stock Picking Makes a Comeback

Market ends the week with some profit-taking.

Interesting PETX Put And Call Options For May 2017

Interesting PETX Put And Call Options For May 2017

Investors in Aratana Therapeutics, Inc saw new options begin trading this week, for the May 2017 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 238 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

This Rally Is No Fun at All

Instead of celebration of good gains, there is grumbling about not keeping pace with the indices.

I Am One of the Underinvested Bulls Right Now

I Am One of the Underinvested Bulls Right Now

It's challenging to put cash to work but I'll keep digging.

Shark Bites: Putting Etsy in My Basket

Shark Bites: Putting Etsy in My Basket

Meanwhile, I continue to hold long-term favorites like Energy Recovery, TPI Composites and Aratana.

Shark Bites: 5 Stocks I Am Playing in This Choppy Action

Shark Bites: 5 Stocks I Am Playing in This Choppy Action

Despite the unsettled market, there are still some interesting picks out there.

Shark Bites: Putting Cash to Work Isn't Easy

I may have to use an index play to get more money to work.

Bounce Has Gone Bust Pretty Quickly

If the market closes weak today, it will be marked with an exclamation point.

'Mad Money' Lightning Round: Abbvie Is a Great Long-Term Position

'Mad Money' Lightning Round: Abbvie Is a Great Long-Term Position

Cramer is sticking with International Paper and likes Advanced Micro Devices.

Jim Cramer's 'Mad Money' Recap: Why You Shouldn't Be Jumping In and Out of Stocks

Jim Cramer's 'Mad Money' Recap: Why You Shouldn't Be Jumping In and Out of Stocks

This is not the time to sell in a panic, Cramer says.

As Market Bears Feast, Opportunities Develop

Is the party over? It's time to protect capital.

Shark Bites: Aratana Therapeutics Makes Its Move

Shark Bites: Aratana Therapeutics Makes Its Move

Typically a move like this will bring in momentum buyers that chase breakouts.

The Pullbacks Are Going to Excite the Bears a Bit

The Pullbacks Are Going to Excite the Bears a Bit

Plus, September is usually the worst month of the year.

'Mad Money' Lightning Round: Lockheed Martin Can Fly to $210

'Mad Money' Lightning Round: Lockheed Martin Can Fly to $210

Cramer says McCormick is up too much and he's not chasing Clayton Williams Energy.

Jim Cramer's 'Mad Money' Recap: The Urge to Merge Rules Wall Street

Jim Cramer's 'Mad Money' Recap: The Urge to Merge Rules Wall Street

There are too many companies in just about every sector of this market, Cramer says.

4 Momentum Stocks You Should Watch Now

4 Momentum Stocks You Should Watch Now

Here are four stocks to watch with strong technical momentum.

Shark Bites: Aratana Therapeutics and Gigamon Are Fresh Additions

Shark Bites: Aratana Therapeutics and Gigamon Are Fresh Additions

The action in the indices is poor; I'll manage positions closely.

Short Interest In Aratana Therapeutics Decreases By 15%

Short Interest In Aratana Therapeutics Decreases By 15%

The most recent short interest data has been released for the 08/15/2016 settlement date, which shows a 706,816 share decrease in total short interest for Aratana Therapeutics, Inc , to 4,048,011, a decrease of 14.87% since 07/29/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

October 21st Options Now Available For Aratana Therapeutics (PETX)

October 21st Options Now Available For Aratana Therapeutics (PETX)

Investors in Aratana Therapeutics, Inc saw new options begin trading today, for the October 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the PETX options chain for the new October 21st contracts and identified one put and one call contract of particular interest.

3 Little Stocks With Big Upside

3 Little Stocks With Big Upside

Some small caps I own are on the move of late, and are still attractive.

Aratana Therapeutics Granted FDA Approval Of NOCITA® (bupivacaine Liposome Injectable Suspension)

Aratana Therapeutics Granted FDA Approval Of NOCITA® (bupivacaine Liposome Injectable Suspension)

Local Post-Operative Analgesia to Provide Extended Pain Control

It May Be Dull, but That's No Reason to Be Negative

It May Be Dull, but That's No Reason to Be Negative

Bears continue to have a tough time gaining traction.

Think Big on These Small Biotechs

Think Big on These Small Biotechs

New drugs give small-cap companies opportunity to expand markets and revenues.

Don't Roll the Dice on Central Bank News

Don't Roll the Dice on Central Bank News

The bears are trying it out on the Bank of England news today, but they may get squeezed.

Buyers Are Finding Support Despite Negative Breadth

Buyers Are Finding Support Despite Negative Breadth

There is still some good speculative action out there.